140 related articles for article (PubMed ID: 28965162)
1. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
Jacobs DI; Liu Y; Gabrusiewicz K; Tsavachidis S; Armstrong GN; Zhou R; Wei J; Ivan C; Calin G; Molinaro AM; Rice T; Bracci PM; Hansen HM; Wiencke JK; Wrensch MR; Heimberger AB; Bondy ML
J Neurooncol; 2018 Jan; 136(1):33-39. PubMed ID: 28965162
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations in EGF and EGFR and glioblastoma outcome.
Sjöström S; Andersson U; Liu Y; Brännström T; Broholm H; Johansen C; Collatz-Laier H; Henriksson R; Bondy M; Melin B
Neuro Oncol; 2010 Aug; 12(8):815-21. PubMed ID: 20197289
[TBL] [Abstract][Full Text] [Related]
4. SSBP2 variants are associated with survival in glioblastoma patients.
Xiao Y; Decker PA; Rice T; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Wiemels JL; Tihan T; Prados MD; Chang SM; Berger MS; Kosel ML; Fridley BL; Lachance DH; O'Neill BP; Buckner JC; Thompson RC; Nabors LB; Olson JJ; Brem S; Madden MH; Browning JE; Wiencke JK; Egan KM; Jenkins RB; Wrensch MR
Clin Cancer Res; 2012 Jun; 18(11):3154-62. PubMed ID: 22472174
[TBL] [Abstract][Full Text] [Related]
5. DNA-repair gene variants are associated with glioblastoma survival.
Wibom C; Sjöström S; Henriksson R; Brännström T; Broholm H; Rydén P; Johansen C; Collatz-Laier H; Hepworth S; McKinney PA; Bethke L; Houlston RS; Andersson U; Melin BS
Acta Oncol; 2012 Mar; 51(3):325-32. PubMed ID: 22017238
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
7. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic variants in the retinoblastoma binding protein 6 gene with the risk of glioma: a case-control study in a Chinese Han population.
Hu D; Zhang S; Zhao Y; Wang S; Wang Q; Song X; Lu D; Mao Y; Chen H
J Neurosurg; 2014 Nov; 121(5):1209-18. PubMed ID: 25127414
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Diagnostic and Prognostic Markers of Immune Suppression in the Blood of Glioma Patients.
Del Bianco P; Pinton L; Magri S; Canè S; Masetto E; Basso D; Padovan M; Volpin F; d'Avella D; Lombardi G; Zagonel V; Bronte V; Della Puppa A; Mandruzzato S
Front Immunol; 2021; 12():809826. PubMed ID: 35069595
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of ATP binding cassette transporter MDR1(1236C>T) gene polymorphism with glioma patients receiving Temozolomide-based chemoradiation therapy in Indian population.
Munisamy M; Munisamy S; Kumar JP; Jose A; Thomas L; Baburaj G; Subbiah V
Pharmacogenomics J; 2021 Apr; 21(2):262-272. PubMed ID: 33589792
[TBL] [Abstract][Full Text] [Related]
12. A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
Pei C; Chen H; Jia X; Yan L; Zou Y; Jiang C; Jin H; Kang C; Jiang T; Ren H
Int J Neurosci; 2013 Feb; 123(2):114-20. PubMed ID: 23057844
[TBL] [Abstract][Full Text] [Related]
13. Common genetic variations of deiodinase genes and prognosis of brain tumor patients.
Bunevicius A; Laws ER; Saudargiene A; Tamasauskas A; Iervasi G; Deltuva V; Smith TR; Bunevicius R
Endocrine; 2019 Dec; 66(3):563-572. PubMed ID: 31452060
[TBL] [Abstract][Full Text] [Related]
14. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests.
Chang JS; Yeh RF; Wiencke JK; Wiemels JL; Smirnov I; Pico AR; Tihan T; Patoka J; Miike R; Sison JD; Rice T; Wrensch MR
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1368-73. PubMed ID: 18559551
[TBL] [Abstract][Full Text] [Related]
15. Inherited variation in immune genes and pathways and glioblastoma risk.
Schwartzbaum JA; Xiao Y; Liu Y; Tsavachidis S; Berger MS; Bondy ML; Chang JS; Chang SM; Decker PA; Ding B; Hepworth SJ; Houlston RS; Hosking FJ; Jenkins RB; Kosel ML; McCoy LS; McKinney PA; Muir K; Patoka JS; Prados M; Rice T; Robertson LB; Schoemaker MJ; Shete S; Swerdlow AJ; Wiemels JL; Wiencke JK; Yang P; Wrensch MR
Carcinogenesis; 2010 Oct; 31(10):1770-7. PubMed ID: 20668009
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
Liu Y; Shete S; Etzel CJ; Scheurer M; Alexiou G; Armstrong G; Tsavachidis S; Liang FW; Gilbert M; Aldape K; Armstrong T; Houlston R; Hosking F; Robertson L; Xiao Y; Wiencke J; Wrensch M; Andersson U; Melin BS; Bondy M
J Clin Oncol; 2010 May; 28(14):2467-74. PubMed ID: 20368557
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk.
Andersson U; Schwartzbaum J; Wiklund F; Sjöström S; Liu Y; Tsavachidis S; Ahlbom A; Auvinen A; Collatz-Laier H; Feychting M; Johansen C; Kiuru A; Lönn S; Schoemaker MJ; Swerdlow AJ; Henriksson R; Bondy M; Melin B
Acta Oncol; 2010 Aug; 49(6):767-75. PubMed ID: 20446891
[TBL] [Abstract][Full Text] [Related]
18. CCDC26 gene polymorphism and glioblastoma risk in the Han Chinese population.
Wei XB; Jin TB; Li G; Geng TT; Zhang JY; Chen CP; Gao GD; Chen C; Gong YK
Asian Pac J Cancer Prev; 2014; 15(8):3629-33. PubMed ID: 24870769
[TBL] [Abstract][Full Text] [Related]
19. Role of monoamine-oxidase-A-gene variation in the development of glioblastoma in males: a case control study.
Sjöberg RL; Wu WY; Dahlin AM; Tsavachidis S; ; Bondy ML; Melin B
J Neurooncol; 2019 Nov; 145(2):287-294. PubMed ID: 31556016
[TBL] [Abstract][Full Text] [Related]
20. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
